{"disease":{"id":"vancomycin","name":"vancomycin"},"drugs":{"marketed":[{"drug_id":"dalfopristin","indication_name":"Vancomycin resistant enterococcus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Synercid","generic_name":"DALFOPRISTIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Streptogramin Antibacterial","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"linezolid","indication_name":"Vancomycin resistant enterococcus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyvox","generic_name":"linezolid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"Oxazolidinone Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria."},{"drug_id":"linezolid","indication_name":"Vancomycin-Resistant Enterococcus Faecium Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyvox","generic_name":"linezolid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"Oxazolidinone Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03456544","title":"Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03221023","title":"Intrawound Vancomycin Prophylaxis for Neural Stimulator","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06392568","title":"Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Abderrahmane Mami Hospital","has_results":false},{"nct_id":"NCT06069206","title":"Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04666948","title":"Precision Dosing of Vancomycin in Critically Ill Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT02667418","title":"Optimal Treatment for Recurrent Clostridium Difficile","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":308,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05481788","title":"External Evaluation of Vancomycin Population Pharmacokinetic Models","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06426836","title":"Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT06001333","title":"Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract","phase":"NA","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Chuncheon Sacred Heart Hospital","has_results":false},{"nct_id":"NCT07364435","title":"Effect of Bed Bathing Methods on VRE Colonization in ICU Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Özkan Kasap","has_results":false},{"nct_id":"NCT07221708","title":"Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT07221370","title":"Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":176,"lead_sponsor_name":"Riverside University Health System Medical Center","has_results":false},{"nct_id":"NCT03806543","title":"The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level","phase":"","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Southeast University, China","has_results":false},{"nct_id":"NCT02241005","title":"Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci","phase":"NA","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05535075","title":"Model-informed Precision Dosing of Vancomycin in Adults","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT05143645","title":"A New Protocol for Continuous Vancomycin Infusion Dosing.","phase":"","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT03822819","title":"Investigation of the Optimal Cocktailed Probiotics for Decolonization of Vancomycin-resistant Enterococci in Human Gut","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Taipei Medical University Shuang Ho Hospital","has_results":false},{"nct_id":"NCT04583098","title":"The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Chuncheon Sacred Heart Hospital","has_results":false},{"nct_id":"NCT05715619","title":"Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":80,"lead_sponsor_name":"Intralytix, Inc.","has_results":false},{"nct_id":"NCT04911270","title":"Clinical Decision Support Tool for Vancomycin Dosing in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05257070","title":"The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04756895","title":"Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"CR-CSSS Champlain-Charles-Le Moyne","has_results":false},{"nct_id":"NCT04758442","title":"Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Ciusss de L'Est de l'Île de Montréal","has_results":false},{"nct_id":"NCT05823116","title":"Continuous vs. Intermittent Infusion Vancomycin","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Aaron Cook","has_results":false},{"nct_id":"NCT04042233","title":"Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":true},{"nct_id":"NCT03944369","title":"VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Kaleido Biosciences","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}